Total Payments
$2,496
2024 Payments
$603.01
Companies
28
Transactions
98
Medicare Patients
111
Medicare Billing
$9,531
Payment Breakdown by Category
Food & Beverage$2,373 (95.1%)
Education$122.33 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,373 | 95 | 95.1% |
| Education | $122.33 | 3 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $451.87 | 20 | $0 (2023) |
| Caldera Medical, Inc | $185.17 | 1 | $0 (2024) |
| Exeltis, USA Inc. | $179.82 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $157.11 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $157.04 | 8 | $0 (2023) |
| Organon LLC | $154.63 | 8 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $147.25 | 6 | $0 (2024) |
| Davol Inc. | $145.38 | 1 | $0 (2020) |
| Aspira Women's Health Inc | $115.77 | 4 | $0 (2023) |
| TherapeuticsMD, Inc. | $81.26 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $603.01 | 16 | Caldera Medical, Inc ($185.17) |
| 2023 | $350.15 | 16 | ABBVIE INC. ($73.14) |
| 2022 | $454.71 | 20 | Organon LLC ($104.83) |
| 2021 | $415.30 | 22 | AbbVie Inc. ($192.35) |
| 2020 | $487.97 | 18 | Davol Inc. ($145.38) |
| 2019 | $184.48 | 6 | AbbVie, Inc. ($86.54) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.48 | General |
| 12/11/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $185.17 | General |
| Category: Urogynaecology | ||||||
| 10/28/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/22/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/24/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Endocrinology | ||||||
| 07/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Hematology | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Biological | ||||||
| 05/17/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: HORMONE THERAPY | ||||||
| 04/23/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 03/21/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Surgical Care | ||||||
| 02/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: HORMONE THERAPY | ||||||
| 01/31/2024 | Exeltis, USA Inc. | NUVESSA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ANTIBIOTIC | ||||||
| 01/25/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 01/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Biological | ||||||
| 01/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: HORMONE THERAPY | ||||||
| 11/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Biological | ||||||
| 10/17/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diagnostics | ||||||
| 08/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Womens Health | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: ETONOGESTREL | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: ETONOGESTREL | ||||||
| 08/02/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Hematology | ||||||
| 07/25/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: WOMENS HEALTH | ||||||
| 06/07/2023 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: OB/GYN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 42 | 58 | $11,094 | $4,321 |
| 2022 | 3 | 44 | 46 | $8,066 | $3,188 |
| 2021 | 1 | 13 | 13 | $3,149 | $1,264 |
| 2020 | 1 | 12 | 14 | $2,288 | $758.14 |
Total Patients
111
Total Services
131
Medicare Billing
$9,531
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 26 | $5,278 | $1,935 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $4,320 | $1,657 | 38.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 17 | 17 | $1,496 | $728.79 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 19 | $3,715 | $1,469 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $2,939 | $1,024 | 34.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 16 | 16 | $1,412 | $695.24 | 49.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $3,149 | $1,264 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $2,288 | $758.14 | 33.1% |
About Dr. Christine Feigal, M.D
Dr. Christine Feigal, M.D is a Obstetrics & Gynecology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2015. The National Provider Identifier (NPI) number assigned to this provider is 1992186670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Feigal, M.D has received a total of $2,496 in payments from pharmaceutical and medical device companies, with $603.01 received in 2024. These payments were reported across 98 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,373).
As a Medicare-enrolled provider, Feigal has provided services to 111 Medicare beneficiaries, totaling 131 services with total Medicare billing of $9,531. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Long Beach, CA
- Active Since 06/17/2015
- Last Updated 02/23/2022
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1992186670
Products in Payments
- MYFEMBREE (Drug) $203.81
- Desara (Device) $185.17
- NEXPLANON (Drug) $154.63
- SLYND (Drug) $152.56
- Progel (Device) $145.38
- LO LOESTRIN FE (Drug) $126.99
- OVA1 (Device) $115.77
- ORIAHNN (Drug) $95.38
- Kyleena (Drug) $94.12
- Orilissa (Drug) $86.54
- ANNOVERA (Drug) $81.26
- ACCRUFER (Drug) $74.99
- ORILISSA (Drug) $73.99
- Veozah (Drug) $72.12
- LILETTA (Drug) $68.97
- SOLOSEC (Drug) $62.95
- Mirena (Drug) $62.92
- Endometrial Ablation System (Device) (Device) $47.14
- ZURZUVAE (Drug) $46.31
- APTIMA (Device) $44.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Long Beach
Ha Nguyen, M.d, M.D
Obstetrics & Gynecology — Payments: $8,782
Obstetrics & Gynecology $8,782
Helen Yang
Obstetrics & Gynecology — Payments: $7,665
Obstetrics & Gynecology $7,665
Patrick Mcmanus, Md, MD
Obstetrics & Gynecology — Payments: $7,373
Obstetrics & Gynecology $7,373
Dr. Neel Iyer, Do, DO
Obstetrics & Gynecology — Payments: $6,555
Obstetrics & Gynecology $6,555
Dr. Jocelyn Craig, M.d, M.D
Obstetrics & Gynecology — Payments: $6,190
Obstetrics & Gynecology $6,190
Briana Livingston
Obstetrics & Gynecology — Payments: $6,084
Obstetrics & Gynecology $6,084